Research programme: dermatological therapeutics - Almirall
Latest Information Update: 27 Nov 2023
Price :
$50 *
At a glance
- Originator Almirall S.A.
- Class Antibodies; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Skin disorders